Bristol-Myers Squibb

Bristol-Myers Squibb Faces 33% Q2 EPS Drop as Dividend Holds at 5.2%

Analysts predict EPS will fall to $1.38 in the July 31 report, driven by patent expirations coupled with currency headwinds